C9 Suppression of TNF alpha and Vascular Endothelial Growth Factor in Therapy
- Date:
- 1997-2008
- Reference:
- SA/KET/A/4/3/10
- Part of:
- The Kennedy Trust for Rheumatology Research
- Archives and manuscripts
About this work
Description
Item relates to patent C9 "Suppression of TNF alpha and Vascular Endothelial Growth Factor in Therapy," invented by Marc Feldmann, Ravinder Maini and Ewa Paleolog under applicant Kennedy Institute of Rheumatology.
Alternative title for the patent is "Use of Tumor Necrosis Factor Alpha and Vascular Endothelial Growth Factor for the Manufacture of a Therapeutic Composition."
The item contains papers relating to the filing and prosecution progress for international PCT, European, Japanese and U.S. applications.
See related material for C9 Espacenet listing (includes patent abstract and digital copies of application).
Publication/Creation
1997-2008
Physical description
1 file (in 5 parts)
Related material
Terms of use
This item is held in offsite storage and requires a longer time for delivery.
Where to find it
Location Status Access Closed stores